Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Update on Commercial Arbitration Loss

6th Oct 2025 07:00

RNS Number : 1098C
Litigation Capital Management Ltd
06 October 2025
 

06 October 2025

Litigation Capital Management Limited

("LCM" or the "Company")

Permission to Appeal Commercial Arbitration Loss Rejected

 

Litigation Capital Management Limited (AIM:LIT), an alternative asset manager specialising in dispute financing solutions internationally, announces that its funded party has been unsuccessful in seeking permission to appeal the commercial arbitration loss that was announced on 1 April 2025. This investment was held at a value of £1.4 million (A$3.0 million) as at 30 June 2025 and that amount will now be written off.

Enquiries

Litigation Capital Management

Patrick Moloney, Chief Executive Officer

David Collins, Chief Financial Officer

Cavendish (Nomad and Broker) 

Tel: 020 7220 0500

Jonny Franklin-Adams and Isaac Hooper (Corporate Finance)

Tim Redfern (Corporate Broking)

 

NOTES TO EDITORS

Litigation Capital Management (LCM) is an alternative asset manager specialising in disputes financing solutions internationally, which operates two business models. The first is direct investments made from LCM's permanent balance sheet capital and the second is third party fund management. Under those two business models, LCM currently pursues three investment strategies: Single-case funding, Portfolio funding and Acquisitions of claims. LCM generates its revenue from both its direct investments and also performance fees through asset management.

Currently headquartered in Sydney, with offices in London and Singapore, LCM listed on AIM in December 2018, trading under the ticker LIT.

www.lcmfinance.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCKZMGGKKLGKZM

Related Shares:

Litigation Cap.
FTSE 100 Latest
Value9,421.62
Change-87.78